Compare Organon & Co. Common Stock (OGN) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Quantum Computing Inc — how do they compare? Organon & Co. Common Stock trades at $13.73 (market cap $3.61B), while Quantum Computing Inc trades at $6.15 (market cap $1.43B). The key difference: Organon & Co. Common Stock is far larger — about 2.5× Quantum Computing Inc's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Quantum Computing Inc for 26 Days on average.
| OGN | QUBT | |
|---|---|---|
Market Cap | $3.61B | $1.43B |
Volume | 1,808,049 | 8,329,766 |
Sector | Health | Technology |
52-Week High | $13.81 | $21.23 |
52-Week Low | $5.70 | $6.31 |
Typical Hold Time | 0 Days | 26 Days |
Enterprise Value | $11.03B | $495.20M |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Quantum Computing Inc. (QUBT) trades at $6.87, down 0.87% on the day, with a bearish technical signal despite bullish oscillators. The company shows dramatic revenue growth from $682K in 2025 to $10M projected for 2026, but remains deeply unprofitable with a -152.45% net income margin. Recent developments include the Dirac-3S quantum system launch and a $42.5M backlog, though rising expenses and negative cash flows pose challenges.
Analysts maintain a bullish stance with a $17.33 consensus price target (75% buy ratings), seeing potential in QUBT's quantum technology expansion. However, investors face significant execution risks, persistent losses, and high volatility typical of pre-commercial quantum stocks. The stock's trajectory depends heavily on commercial adoption and cost management amid intense sector competition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
